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ABSTRACT
The nonsense-mediated mRNA decay (NMD)
pathway is a highly conserved surveillance mechan-
ism that is present in all eukaryotes. It prevents the
synthesis of truncated proteins by selectively
degrading mRNAs harbouring premature termin-
ation codons (PTCs). The core NMD effectors
were originally identified in genetic screens in
Saccharomyces cerevisae and in the nematode
Caenorhabditis elegans, and subsequently by
homology searches in other metazoans. A
genome-wide RNAi screen in C. elegans resulted
in the identification of two novel NMD genes that
are essential for proper embryonic development.
Their human orthologues, DHX34 and NAG/NBAS,
are required for NMD in human cells. Here, we find
that the zebrafish genome encodes orthologues of
DHX34 and NAG/NBAS. We show that the
morpholino-induced depletion of zebrafish Dhx34
and Nbas proteins results in severe developmental
defects and reduced embryonic viability. We also
found that Dhx34 and Nbas are required for degrad-
ation of PTC-containing mRNAs in zebrafish
embryos. The phenotypes observed in both Dhx34
and Nbas morphants are similar to defects in Upf1,
Smg-5- or Smg-6- depleted embryos, suggesting
that these factors affect the same pathway and con-
firming that zebrafish embryogenesis requires an
active NMD pathway.
INTRODUCTION
The nonsense-mediated decay (NMD) pathway plays a
central role in the control of gene expression. It is an
elaborate surveillance mechanism that triggers the degrad-
ation of mRNAs containing premature termination
codons (PTCs). By doing so, it prevents the accumulation
of truncated proteins that may interfere with cellular
function [reviewed by refs. (1,2)]. The importance of
NMD is highlighted by the fact that it not only regulates
transcripts harboring nonsense mutations but also regu-
lates an important fraction of the transcriptome. Gene
expression proﬁles in Saccharomyces cerevisae,
Drosophila melanogaster and human cells-lacking individ-
ual NMD factors indicated that up to 10% of cellular
transcripts are regulated by NMD (3–6). Approximately,
a third of all inherited genetic disorders are caused by
frameshift or nonsense mutations giving rise to PTCs.
Thus, NMD may act to modulate the phenotypic
outcome of this type of diseases with NMD factors
being potential targets for therapeutic intervention (7,8).
NMD effectors were originally identiﬁed in genetic
screens conducted in both S. cerevisae and Caenorhabditis
elegans. Seven genes with a central role in NMD were
identiﬁed in nematodes. In addition to their NMD pheno-
type, mutations of these genes cause abnormal morpho-
genesis of the male bursa and the hermaphrodite vulva;
for this reason they were named smg-1-7 (for suppressor
with morphological effect on genitalia) (9–11). In
S. cerevisae, three NMD genes, termed UPF1-3 (for
up-frameshift) are orthologues of the C. elegans smg-2,
smg-3 and smg-4 (12,13). Subsequently, orthologues for
the smg genes have been identiﬁed in several species
[reviewed by ref. (14)]. Only recently, four additional
NMD factors have been identiﬁed in C. elegans and in
human cells: NAG/NBAS, DHX34, SMG-8 and SMG-9
(15). NAG/NBAS (for neuroblastoma ampliﬁed gene/
neuroblastoma ampliﬁed sequence) and DHX34 are the
human homologues of C. elegans smgl-1 and smgl-2, two
essential NMD genes that were identiﬁed in a
genome-wide RNAi screen. Both the nematode and
*To whom correspondence should be addressed. Tel: +44 131 777 3573; Fax: +44 131 777 3583; Email: Elizabeth.Patton@hgu.mrc.ac.uk
Correspondence may also be addressed to Javier F. Ca´ceres. Tel: +44 131 467 8426; Fax: +44 131 467 8456; Email: Javier.Caceres@hgu.mrc.ac.uk
The authors wish it to be known that, in their opinion, the ﬁrst two authors should be regarded as joint First Authors.
3686–3694 Nucleic Acids Research, 2011, Vol. 39, No. 9 Published online 11 January 2011
doi:10.1093/nar/gkq1319
 The Author(s) 2011. Published by Oxford University Press.
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/
by-nc/2.5), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
human genes have been shown to function in the NMD
pathway (16).
A central component of the NMD pathway is the
protein UPF1/SMG-2, an ATP-dependent RNA
helicase that undergoes cycles of phosphorylation/
dephosphorylation that are essential for NMD.
Phosphorylation of UPF1/SMG-2 is carried out by
SMG-1, a member of the phosphatidylinositol kinase
superfamily of protein kinases (17,18). Both SMG-8 and
SMG-9 were identiﬁed as subunits of the SMG-1 kinase
complex and shown to be required for NMD in both
humans and nematodes (19). All other known SMG
genes affect the state of SMG-2 phosphorylation, with
SMG-1, SMG-3 and SMG-4 being required for SMG-2
phosphorylation. By contrast, SMG-5, SMG-6 and
SMG-7 have a role in SMG-2 dephosphorylation in a
process that also involves the catalytic and structural
subunits of protein phosphatase 2A (PP2A) (20,21).
Recently, it was found that SMG-6 initiates endo-
nucleolytic cleavage in the vicinity of the PTC in both
D. melanogaster and in humans. These studies highlighted
that endonucleolytic cleavage is a conserved feature in
metazoan NMD (22,23). A link between the NMD ma-
chinery and the general decay complex may be provided
by the human proline-rich nuclear receptor coregulatory
protein 2 (PNRC2), which was shown to interact with
both hyperphosphorylated UPF1- and the decapping ac-
tivator, DCP1a (24). Furthermore, SMG-7 links mRNA
surveillance and mRNA decay by forming a complex with
SMG-5 and UPF1 and targeting bound mRNAs for
mRNA decay (25). A surveillance complex, termed
SURF, comprising SMG-1, UPF1 and the eukaryotic
release factors eRF1and eRF3 is formed on mRNAs
during recognition of a PTC. This step is followed by
the interaction of the SURF complex with UPF2, UPF3
and components of the EJC that are bound to a down-
stream exon–exon boundary. This results in the formation
of a decay-inducing complex (DECID) that triggers UPF1
phosphorylation and the dissociation of eRF1,3 (26)
[reviewed by ref. (27)]. Interestingly, UPF1 can interact
with the exon junction complex (EJC) either through
UPF2 or UPF3b, indicating the existence of alternative
branches of the NMD pathway (28,29).
A critical aspect of the NMD pathway is how to distin-
guish a premature from a normal termination codon.
Although for the most part NMD effectors are conserved
throughout evolution, different strategies have been found
for PTC deﬁnition. In mammalian cells, pre-mRNA
splicing and NMD are intimately linked, and the
position of a termination codon relative to the last
intron will determine whether it is interpreted as a PTC
(30) [reviewed by ref. (31)]. This positional information is
determined by the EJC, a multiprotein complex that is
deposited on every exon junction following pre-mRNA
splicing, marks the position of exon–exon boundaries
and recruits NMD factors (32,33) [for a review see ref.
(34)]. However, an intron-independent NMD mechanism
that measures the distance between the termination codon
and the poly(A)-binding protein PABPC1 acts to deter-
mine whether the stop codon will be recognized as a PTC
in human cells (35–37). The requirement of exon
boundaries to deﬁne a PTC has also been found in
zebraﬁsh and in plants (38–40) [for a review see ref.
(41)]. In contrast, in invertebrates deﬁnition of a PTC
occurs independently of exon boundaries as shown in
yeast, in C. elegans and in Drosophila (16,42,43).
In this study, we focus on the functional characteriza-
tion of two novel NMD factors in the zebraﬁsh, Danio
rerio. We found that the zebraﬁsh genome encodes
orthologues of NAG/NBAS/smgl-1 and DHX34/smgl-2.
These factors were identiﬁed in a genome-wide RNAi
screen in C. elegans and shown to function in the NMD
pathway in both nematodes and human cells. Here, we
show that both genes are required for zebraﬁsh develop-
ment and function in the NMD pathway in Danio rerio.
The phenotypes observed in both nbas and dhx34
morphants are similar to those described when depleting
NMD core factors, such as Upf1, Smg-5- or Smg-6 (38).
This strongly suggests that these genes affect the same
pathway and conﬁrm that zebraﬁsh embryogenesis
requires an active NMD pathway.
MATERIALS AND METHODS
Animal husbandry
Zebraﬁsh embryos and adults were raised and maintained
at 28.5C on a 12 h light/dark cycle. Embryos were col-
lected by pair matings of a wild-type stain (AB-TPL) and
the Slc24a5/ (Golden) line and were staged as described
previously (44).
Microinjection of embryos
Injections were performed on wild-type and slc24a5/
zebraﬁsh embryos using a nitrogen-powered Picospritzer
III microinjector (Intracel) conjugated to a Nikon SMZ
1000 stereomicroscope. One- to four-cell stage embryos
were injected with 4 nl of 250 mM translation block (TB)
morpholino oligonucleotides (MOs) against upf1 (38),
dhx34 and nbas, splice-site MOs against dhx34 and nbas,
as well as their respective 5 bp-mismatch control MOs
(Gene-Tools LLC). MO sequences used are provided on
Supplementary Table S1. For the mRNA rescue experi-
ments, 250 mM of TB and splice-site Dhx34 and Nbas
MOs were co-injected with 35 pg of capped DHX34 and
NAG/NBAS human mRNA, respectively, in a total
volume of 4 nl. Capped human DHX34 and NAG/NBAS
mRNAs were synthesized using the mMessage mMachine
T7 kit (Ambion) according to the manufacturer’s
instructions.
Wholemount in situ hybridization of morphants
Zebraﬁsh embryos [24 hours post-fertilization (hpf)] were
dechorionated manually and ﬁxed overnight in 4%
parafolmaldehyde/PBS at 4C. The embryos were
serially dehydrated and stored overnight in methanol at
20C. Antisense and sense dhx34 and nbas mRNA
probes were synthesized and digoxigenin-labelled in vitro
(Roche) and whole-mount in situ hybridization was
carried out as previously described (45). An anti-
digoxigenin antibody was incubated in a 1:5000 dilution
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overnight and the samples were stained in BM Purple
alkaline phosphatase (Roche) for 2 h. The reaction was
stopped in 20mM EDTA/PBS. Processed embryos were
mounted in 100% glycerol and were imaged using a Nikon
SMZ1500 stereomicroscope in conjunction with a
Q-imaging camera.
RNA isolation and RT- PCR
Control and MO-injected embryos (24 hpf) were manually
dechorionated and directly homogenized in 500 ml
TRIZOL (Invitrogen) using a 25G needle. RNA was
isolated following manufacturer’s instructions. Real-time
RT–PCR was performed using target-speciﬁc primers and
SuperScriptIII Platinum SYBR Green One-Step
qRT-PCR Kit (Invitrogen). Real-time RT–PCT was run
on Bio-Rad CFX96 cycler. Total RNA (300 ng) was used
in 20 ml reaction, and each sample was run in triplicates.
Data analysis were performed using the Bio-Rad CFX
manager software. For the analysis of dhx34 and nag
splicing defects induced by the splice-site targeting MOs,
RNA was ampliﬁed using target-speciﬁc primers and
SuperScriptIII One-Step RT-PCR kit (Invitrogen). PCR
products were resolved on 1.5% agarose gel. Oligonu-
cleotide sequences are provided on Supplementary
Table S2.
RESULTS
Dhx34 and Nbas, which are highly conserved between
zebraﬁsh and humans, are expressed throughout
zebraﬁsh development
We have previously shown that DHX34 and NAG/NBAS
are highly conserved between C. elegans and humans and
function as NMD factors in both organisms (16). Here, we
identiﬁed the zebraﬁsh homologues of these NMD factors
and found that the zebraﬁsh proteins harbour the same
functional domains of their human counterparts and share
a high degree of conservation (Figure 1). The human
DHX34 protein is a member of the ATP-dependent
RNA helicase family and displays four protein domains
typically associated with ATP-dependent RNA helicases,
which are present and conserved in zebraﬁsh (Figure 1)
[for reviews see refs. (46,47)]. Human NAG/NBAS was
originally identiﬁed as a gene ampliﬁed in human
neuroblastomas (48,49). It contains WD40 repeats
(b-propeller domain; PFAM domain PF00400) in the
N-terminal part of the protein, and a SEC39 domain
(PFAM domain PF08314) found in proteins involved in
the secretory pathway. Both of these domains are also
conserved in the zebraﬁsh protein (Figure 1).
To address the role of dhx34 and nbas in vertebrate
development, we ﬁrst examined their RNA expression
patterns by wholemount RNA in situ hybridization. We
found dhx34 and nbas to be expressed during early devel-
opment (1000-cell stage) prior to gastrulation, as well as
following gastrulation cell movements at 10 hpf when the
embryo form starts to become apparent (Figure 2).
Expression of dhx34 appeared throughout the embryo at
these stages, while we observed a slight gradient of nbas
expression towards the posterior end of the embryo at 10
hpf. No expression of dhx34 or nbas was detected in the
yolk of the zebraﬁsh, nor with the sense mRNA control,
indicating the speciﬁcity of RNA expression in the
embryo. Thus, like other NMD effectors in zebraﬁsh,
dhx34 and nbas are expressed ubiquitously during early
development (38).
Dhx34 and Nbas are essential for zebraﬁsh development
In the developing zebraﬁsh, the core NMD factors (Upf1,
Upf2, Smg5, Smg6 and Smg7) have an essential role
during zebraﬁsh embryogenesis (38). However, the role
of the recently identiﬁed NMD factors Dhx34 and Nbas
in vertebrate development is unknown. To address this
question, we injected zebraﬁsh embryos with TB or
splice-site MOs to prevent the production of functional
Dhx34 or Nbas during zebraﬁsh development. First, we
recapitulated previous experiments and showed that TB
MO that prevent the production of functional Upf1
severely affected zebraﬁsh development. As reported pre-
viously, morphants with intermediate and severe pheno-
types were observed (Supplementary Figure S1) (38). As a
control, we used MOs containing the same sequence as the
Upf1, Dhx34 or Nbas MOs, but including a 5 bp
mismatch as indicated in Supplementary Table S1. We
tested the efﬁciency of the splice-site MOs by PCR of
the injected zebraﬁsh embryos, and conﬁrmed their efﬁ-
ciency in blocking pre-mRNA splicing of the targeted gene
(data not shown). We found that depletion of Dhx34
resulted in embryonic defects similar to those observed
upon Upf1 depletion (Figure 3 and Supplementary
Figure S1) demonstrating that this gene is essential for
development. The Dhx34 morphants could be grouped
into two main classes, those with an intermediate pheno-
type or with a severe phenotype (Figure 3A). Those with
an intermediate phenotype were morphologically develop-
mentally delayed, with aberrant formation of head and
tail; however, these animals developed eye placodes and
somites (TB MO n=592/1298; splice-site block MO
n=487/1063). In contrast, animals in the severe pheno-
type category were severely developmentally arrested, dis-
playing yolk extension defects, abnormal somite
formation and areas of opaque tissue in the eye and
brain, which is indicative of necrotic tissue (TB MO
Figure 1. Dhx34 and Nbas are conserved between zebraﬁsh and
human. Schematic representation of the zebraﬁsh Dhx34 and Nbas
proteins. The shaded boxes represent the regions of sequence conser-
vation within proteins; the level of conservation is indicated. Functional
domains associated with ATP-dependent RNA helicases in Dhx34
(DEXDc, HELICc, PFAM:HA2 and PFAM:DUF 1605) are indicated.
Predicted functional domains of the Nbas protein are indicated.
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n=451/1298; splice-site block MO n=374/1063)
(Figure 3A).
Next, we used MOs designed to target Nbas to deter-
mine whether this gene is required for vertebrate develop-
ment. Nbas control MOs had no effect on embryonic
development (5 bp mismatch TB MO n=512/512; 5 bp
mismatch splice-site MO n=506/506). In contrast, both
Nbas TB-MO and Nbas splice-site MO caused strong
developmental phenotypes that were grouped into two
categories (Figure 4A). The intermediate phenotype
showed areas of necrosis in the brain and neural struc-
tures, and like the Dhx34 morphants, showed abnormal
Figure 3. Dhx34 is required for proper embryonic development in zebraﬁsh. (A) Translation block and splice site MOs against zebraﬁsh Dhx34
cause a distinctive range of developmental phenotypes at 24hpf characterized by shortening of the anteroposterior axis, somite malformation and
signiﬁcant reduction in head size. Morphants injected with the mismatch control MOs are indistinguishable from uninjected wild-type embryos. (B)
Co-injection of Dhx34 translation block MO and human full-length DHX34 mRNA rescued the morphant phenotype in 73.8% of the injected
embryos at 24 hpf. Expression of the mRNA alone has no overt effect on development. The numbers beside each panel indicate the percentage of
embryos with the observed phenotype. Numbers in brackets correspond to the total of analysed embryos.
Figure 2. Dhx34 and Nbas are ubiquitously expressed during zebraﬁsh embryogenesis. Wholemount in situ hybridization against dhx34 and nbas
using antisense riboprobes revealed ubiquitous expression of dhx34 and nbas transcripts (seen as purple staining) during early zebraﬁsh development.
No signiﬁcant staining was detected using the control sense probes.
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somites assembled like a ‘stack of pennies’ (TB MO
n=399/808; splice-site MO n=402/866). Nbas mor-
phants with a severe phenotype revealed embryos with
few recognizable structures that had completed gastrula-
tion stages and formed a small body on top of the yolk sac,
with necrotic tissues in the anterior and posterior regions
(TB MO n=278/808; splice-site MO n=315/866). A
summary of morphant phenotypes and viability for both
DhX34 and Nbas is indicated on Table 1.
Thus, our data demonstrated essential functions for
Dhx34 and Nbas during zebraﬁsh embryonic develop-
ment. The similar embryonic phenotypes associated
with both the TB and splice-site MOs for both genes
strongly suggest that the phenotypes can be directly
attributed to loss of gene function, rather than
non-speciﬁc effects of the MOs. Notably, even though
the embryonic phenotypes do not point towards speciﬁc
developmental targets for Dhx34 and Nbas, the
morphants share overall similarity with the Upf1, Upf2,
Smg5 and Smg6 morphants, which is most apparent in the
somite structures and brain necrosis (Supplementary
Figure S1). This is in contrast to the somewhat more
speciﬁc developmental phenotypes observed for the
Smg7 and Upf3a/b morphants (38). We suggest that the
pleiotropic morphant phenotypes indicate that Nbas and
Dhx34 are involved in the control of multiple biological
targets, and this is most likely associated with their
common role with upf1, upf2, smg5 and smg6 in the
NMD pathway.
Human DHX34 and NAG/NBAS compensate for loss of
Dhx34 and Nbas in zebraﬁsh development
Human DHX34 and NAG/NBAS share 58.1 and
63.8% identity to the zebraﬁsh Dhx34 and Nbas
proteins (Figure 1). We hypothesized that the function
of the human and zebraﬁsh genes are similar. To
address the functional conservation between the two
species, we investigated whether expression of human
mRNA encoding either DHX34 or NAG/NBAS was able
to rescue the developmental defects induced by MOs. As
an important control, we observed no developmental
abnormalities in embryos that expressed human mRNA
for DHX34 (n=194) or NAG/NBAS (n=96) (Figures 3B
and 4B, respectively). Next, we expressed human DHX34
or NAG/NBAS in zebraﬁsh Dhx34 or Nbas morphant
animals, respectively. Sufﬁcient differences in the
Figure 4. Nbas is essential for zebraﬁsh embryonic development. (A) Injections with translation block and splice site MOs against zebraﬁsh nbas
reproduced the developmental phenotype observed in Upf1 and Dhx34 morphants. (B) Co-injection of Nbas translation block MO and human full
length NAG/Nbas mRNA rescued the morphant phenotype in the majority of the embryos at 24 hpf. Expression of the mRNA alone had no effect
on embryonic development. The numbers beside each panel represent the percentage of embryos showing each phenotype and in brackets is the total
number of the analysed embryos.
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translation start site ensure that the Dhx34 or Nbas MOs
would not be active against the human DHX34 or NAG/
NBAS mRNA species. We found that human DHX34
was able to completely rescue the developmental malfor-
mations found in Dhx34 morphants (n=223/302)
(Figure 3B). A small proportion of injected embryos
showed intermediate rescue with minor developmental
defects (n=79/302). Likewise, human NAG/NBAS was
also able to partially (n=27/103) and completely rescue
(n=76/103) the Nbas morphant phenotypes (Figure 4B).
These experiments demonstrate that zebraﬁsh dhx34
and nbas are the functional homologues of human
DHX34 and NAG/NBAS, respectively. The ability of
human DHX34 and NAG/NBAS mRNAs to rescue the
severe embryonic phenotypes of the morphants further
indicates that the phenotypes described are speciﬁc to
the loss of Dhx34 or Nbas, rather than non-speciﬁc
effects of the MO.
Dhx34 and Nbas are required for NMD in
developing zebrafish
The zebraﬁsh goldenb1 mutant carries a nonsense mutation
in the ﬁfth exon of the slc24a5 mRNA and as a result the
expression of slc24a5 transcript is undetectable in the
melanocyte precursor cells due to NMD-mediated degrad-
ation. Consequently, goldenb1 mutant ﬁsh are defective in
melanocyte production and exhibit a hypopigmentation
phenotype (50). It was previously shown that depletion
of Upf1 results in upregulation of the slc24a5 nonsense
transcript in goldenb1 mutant embryos (38). To conclusive-
ly demonstrate whether Dhx34 and Nbas are required for
NMD in zebraﬁsh, we tested whether MO-mediated
depletion of zebraﬁsh Dhx34 and Nbas resulted in an
increase in the level of slc24a5 endogenous transcript in
the golden mutant strain. The expression of slc24a5
mRNA was analysed by real-time RT–PCR and
normalized to the level of the melanin biosynthesis
marker dct mRNA which is also expressed in melanocyte
precursor cells. First, we found that the level of slc24a5
was not affected by Dhx34 or Nbas knockdown in a
wild-type strain (Figure 5A). In the goldenb1 mutant
strain, we conﬁrmed that Upf1 knockdown resulted in
an 5-fold up-regulation of slc24a5 mRNA, whereas
Upf1 mismatch control had no signiﬁcant effect.
Importantly, MO-induced depletion of Dhx34 and Nbas
also restored the expression of the mutant transcript
in a manner similar to the one observed following Upf1
depletion (Figure 5B). Injections of the corresponding
mismatch control MOs did not change the level of the
Table 1. Summary of morphant phenotypes and viability
Severe Intermediate
(%)
Normal (%) Morphant survival
(5 dpf) (%)
Control survival
(5 dpf) (%)Percentage of injected embryos (n)
Dhx34 TB MO 34.7 (1298) 45.60 19.60 69.20 99.2 (476)
Dhx34 SS MO 35.6 (1063) 45.80 19.00 72.50 99.3 (458)
Dhx34 mRNA – – 100 (194) – 92.80
Dhx34 TB MO+mRNA – 26.10 73.8 (302) 81.10 –
Nbas TB MO 34.4 (808) 49.40 16.20 67.30 99.4 (512)
Nbas SS MO 36.4 (866) 46.40 17.20 73.30 99.0 (506)
Nbas mRNA – – 100 (96) – 97.90
Nbas TB MO+mRNA – 26.20 73.8 (103) 98.70 –
Upf1 TB MO 39.2 (495) 46.10 14.70 – –
Uninjected control (%) – – – – 100.00
Values in parenthesis represent n.
Figure 5. Both Dhx34 and Nbas are required for the in vivo degradation of the nonsense slc25a5 transcript in zebraﬁsh. Expression of slc25a5
mRNA was measured in wild-type (A) and goldenb1 mutant (B) uninjected embryos, or embryos injected with indicated MOs, by real-time RT–PCR.
The level of slc25a5 transcript was normalized to dct mRNA. The normalized values were then divided by values for uninjected samples (no MO)
and expressed as relative mRNA levels.
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aberrant transcript. These results indicate that zebraﬁsh
Dhx34 and Nbas are required for the degradation of
nonsense transcripts.
In summary, we have shown that zebraﬁsh Dhx34 and
Nbas are required for embryonic development in this ver-
tebrate. Three lines of evidence strongly suggest a role for
these factors in the NMD pathway. First, their depletion
leads to phenotypes very similar to those observed with
core NMD factors. Second, the ability of human NAG/
NBAS or DHX34 mRNAs to rescue the phenotypes
observed in zebraﬁsh embryos depleted of Dhx34 or
Nbas highlights their functional conservation. Finally,
we have shown that both proteins are required for the
degradation of a PTC-containing mRNA in zebraﬁsh
embryos. Altogether, this suggests that Dhx34 and Nbas
are novel NMD factors in zebraﬁsh and conﬁrms the
requirement of an active NMD pathway for proper
development.
DISCUSSION
NMD is a highly conserved mechanism that is present in
all eukaryotes. Whereas the central NMD effectors are
conserved across species, the mechanism by which a
PTC is recognized presents important differences through-
out evolution. The main divergence is whether NMD is
coupled or not to pre-mRNA splicing. In humans,
zebraﬁsh and other vertebrates, as well as in plants,
NMD is tightly coupled to pre-mRNA splicing via
proteins of the EJC [reviewed by ref. (8)]. By contrast, in
Drosophila and S. cerevisae, NMD has been shown to
operate independently of splicing, with the use of different
mechanism/s to deﬁne a PTC. Interestingly, a ‘mixed
system’ seems to be operating in S. pombe, since splicing
enhances NMD but in an EJC-independent manner (51).
It may well be that splicing and deposition of the EJC
may act as ‘enhancers’ of NMD in organisms where
pre-mRNA splicing is prominent. It is also of importance
that NMD regulates an important fraction of the tran-
scriptome, affecting not only mRNAs that harbour a
PTC, but also naturally occurring transcripts [for a
review see ref. (41)].
Here, we have identiﬁed the zebraﬁsh homologues of
the NMD factors NAG/NBAS/SMGL-1 and DHX34/
SMGL-2. These NMD factors were initially identiﬁed in
a reporter-based genome-wide RNAi screen in the
nematode C. elegans and shown to act as NMD factors
both in nematodes and also in human cells (16).
Interestingly, these two genes deﬁne a novel class of
nematode NMD factors that are essential for embryonic
development. Mutations in the core smg-1-7 genes do not
result in lethality, strongly suggesting that NMD is not an
essential process in nematodes, and pointing to additional
functions of SMGL-1, 2 in this organism. By contrast,
targeted disruption of Rent1/UPF1 results in embryonic
lethality in the mouse (52), whereas morpholino-mediated
depletion of core SMG proteins in zebraﬁsh results in
severe developmental defects ((38) and this study). This
could reﬂect the fact that NMD is not essential in
C. elegans but is required for viability in vertebrates or
it could point to additional cellular processes in which
NMD factors are involved. For instance, SMG-2/UPF1
has been shown to be also required for genome stability in
human cells (53). Furthermore, a role for SMG-2/UPF1 in
alternative mRNA degradation pathways has been
described. For example, in SMD (Staufen-mediated
decay), UPF1 is recruited to 30-UTRs of mRNAs bound
by the RNA binding protein STAUFEN 1 and elicits
mRNA degradation (54). It also functions in regulated
degradation of histone mRNAs, where is recruited by
the stem–loop binding protein (55).
The phenotypes observed following morpholino-
mediated depletion of Nbas and Dhx34 resemble those
observed for core NMD factors in zebraﬁsh (38). This
strongly suggests that NMD is indeed an essential
process in this organism. Importantly, we could demon-
strate a role for these two factors in NMD in vivo. Of
course, we cannot rule out additional cellular functions
for Nbas and Dhx34 in Danio rerio. Future studies using
expression proﬁles in human, zebraﬁsh and C. elegans
depleted of individual NMD factors will result in the iden-
tiﬁcation of RNA targets and pathways of NMD regula-
tion throughout evolution. This could also lead to the
identiﬁcation of additional cellular functions, other than
NMD, for Dhx34 and Nbas.
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